Mammography Screening in Three Finnish Residential Areas: Comprehensive Population-based Study of Breast Cancer Incidence and Incidence-based Mortality 1976-2009

Overview

Journal Br J Cancer

Specialty Oncology

Date 2015 Feb 18

PMID 25688742

Citations 4

Authors

I Parvinen

S Heinavaara

A Anttila

H Helenius

P Klemi

L Pylkkanen

Affiliations

Soon will be listed here.

Abstract

Background: The aim of this study was to evaluate the effectiveness of a large-scale screening programme for breast cancer (BC) in Turku, Finland. Incidence and incidence-based mortality (IBM) figures were compared with the areas applying different screening policies.

Methods: Deaths and person-time of women aged 40-84 were assessed for the period 1976-1986 (prescreening era) and the periods 1987-1997 and 1998-2009 (screening periods) using incidence and IBM by age at diagnosis and at death. There was a total of 40.7 million women-years, 83 497 invasive BCs obtained from the Finnish Cancer Registry; 17 508 BC deaths were linked with the data from Statistics Finland.

Results: In Turku, a significant (> 20%) reduction in IBM occurred during 1987-2009 among women aged 60-74 years at diagnosis compared with Helsinki (IBMRR: 0.75, 95% CI: 0.57-1.00), and in women aged 75-84 years at death compared with the rest of Finland (IBMRR: 0.72, 95% CI: 0.53-0.96).

Conclusions: The wide mammography screening programme in Turku was effective in decreasing BC mortality in the elderly age groups. These results support the implementation of BC screening from age 50 up to 74 years.

Citing Articles

Screening for breast cancer: a systematic review update to inform the Canadian Task Force on Preventive Health Care guideline.

Bennett A, Shaver N, Vyas N, Almoli F, Pap R, Douglas A Syst Rev. 2024; 13(1):304.

PMID: 39702409 PMC: 11656969. DOI: 10.1186/s13643-024-02700-3.

Differences in mammography screening attendance among non-Western immigrants in Denmark, Finland, Iceland and Norway.

Njor S, Heinavaara S, Stefansdottir H, Nygard M, Gudmundsdottir E, Bhargava S Prev Med Rep. 2023; 36:102516.

PMID: 38116274 PMC: 10728433. DOI: 10.1016/j.pmedr.2023.102516.

Worldwide Review and Meta-Analysis of Cohort Studies Measuring the Effect of Mammography Screening Programmes on Incidence-Based Breast Cancer Mortality.

Dibden A, Offman J, Duffy S, Gabe R Cancers (Basel). 2020; 12(4).

PMID: 32326646 PMC: 7226343. DOI: 10.3390/cancers12040976.

Effect of population breast screening on breast cancer mortality up to 2005 in England and Wales: an individual-level cohort study.

Johns L, Coleman D, Swerdlow A, Moss S Br J Cancer. 2016; 116(2):246-252.

PMID: 27931047 PMC: 5243996. DOI: 10.1038/bjc.2016.415.

References

Moss S . Overdiagnosis and overtreatment of breast cancer: overdiagnosis in randomised controlled trials of breast cancer screening. Breast Cancer Res. 2005; 7(5):230-4. PMC: 1242166. DOI: 10.1186/bcr1314. View

Sarkeala T, Heinavaara S, Anttila A . Breast cancer mortality with varying invitational policies in organised mammography. Br J Cancer. 2008; 98(3):641-5. PMC: 2243161. DOI: 10.1038/sj.bjc.6604203. View

Puliti D, Zappa M . Breast cancer screening: are we seeing the benefit?. BMC Med. 2012; 10:106. PMC: 3447729. DOI: 10.1186/1741-7015-10-106. View

Heinavaara S, Sarkeala T, Anttila A . Overdiagnosis due to breast cancer screening: updated estimates of the Helsinki service study in Finland. Br J Cancer. 2014; 111(7):1463-8. PMC: 4183845. DOI: 10.1038/bjc.2014.413. View

Otto S, Fracheboud J, Verbeek A, Boer R, Reijerink-Verheij J, Otten J . Mammography screening and risk of breast cancer death: a population-based case-control study. Cancer Epidemiol Biomarkers Prev. 2011; 21(1):66-73. DOI: 10.1158/1055-9965.EPI-11-0476. View

Lund E, Mode N, Waaseth M, Thalabard J . Overdiagnosis of breast cancer in the Norwegian Breast Cancer Screening Program estimated by the Norwegian Women and Cancer cohort study. BMC Cancer. 2014; 13:614. PMC: 3884013. DOI: 10.1186/1471-2407-13-614. View

Coleman M, Forman D, Bryant H, Butler J, Rachet B, Maringe C . Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995-2007 (the International Cancer Benchmarking Partnership): an analysis of population-based cancer registry data. Lancet. 2010; 377(9760):127-38. PMC: 3018568. DOI: 10.1016/S0140-6736(10)62231-3. View

Roder D, Houssami N, Farshid G, Gill G, Luke C, Downey P . Population screening and intensity of screening are associated with reduced breast cancer mortality: evidence of efficacy of mammography screening in Australia. Breast Cancer Res Treat. 2008; 108(3):409-16. DOI: 10.1007/s10549-007-9609-5. View

Tabar L, Vitak B, Chen T, Yen A, Cohen A, Tot T . Swedish two-county trial: impact of mammographic screening on breast cancer mortality during 3 decades. Radiology. 2011; 260(3):658-63. DOI: 10.1148/radiol.11110469. View

10.

Numan Hellquist B, Duffy S, Abdsaleh S, Bjorneld L, Bordas P, Tabar L . Effectiveness of population-based service screening with mammography for women ages 40 to 49 years: evaluation of the Swedish Mammography Screening in Young Women (SCRY) cohort. Cancer. 2010; 117(4):714-22. DOI: 10.1002/cncr.25650. View

11.

Immonen-Raiha P, Kauhava L, Parvinen I, Holli K, Kronqvist P, Pylkkanen L . Mammographic screening reduces risk of breast carcinoma recurrence. Cancer. 2004; 103(3):474-82. DOI: 10.1002/cncr.20793. View

12.

Hofvind S, Ursin G, Tretli S, Sebuodegard S, Moller B . Breast cancer mortality in participants of the Norwegian Breast Cancer Screening Program. Cancer. 2013; 119(17):3106-12. PMC: 4288930. DOI: 10.1002/cncr.28174. View

13.

Gorini G, Zappa M, Miccinesi G, Paci E, Costantini A . Breast cancer mortality trends in two areas of the province of Florence, Italy, where screening programmes started in the 1970s and 1990s. Br J Cancer. 2004; 90(9):1780-3. PMC: 2409759. DOI: 10.1038/sj.bjc.6601744. View

14.

Nickson C, Mason K, English D, Kavanagh A . Mammographic screening and breast cancer mortality: a case-control study and meta-analysis. Cancer Epidemiol Biomarkers Prev. 2012; 21(9):1479-88. DOI: 10.1158/1055-9965.EPI-12-0468. View

15.

Duffy S, Tabar L, Olsen A, Vitak B, Allgood P, Chen T . Absolute numbers of lives saved and overdiagnosis in breast cancer screening, from a randomized trial and from the Breast Screening Programme in England. J Med Screen. 2010; 17(1):25-30. PMC: 3104821. DOI: 10.1258/jms.2009.009094. View

16.

Gotzsche P, Jorgensen K, Zahl P, Maehlen J . Why mammography screening has not lived up to expectations from the randomised trials. Cancer Causes Control. 2011; 23(1):15-21. DOI: 10.1007/s10552-011-9867-8. View

17.

Ursin G . Mammographic screening debate on study design: a need to move the field forward. BMC Med. 2012; 10:164. PMC: 3599232. DOI: 10.1186/1741-7015-10-164. View

18.

Zackrisson S, Andersson I, Janzon L, Manjer J, Garne J . Rate of over-diagnosis of breast cancer 15 years after end of Malmö mammographic screening trial: follow-up study. BMJ. 2006; 332(7543):689-92. PMC: 1410836. DOI: 10.1136/bmj.38764.572569.7C. View

19.

Autier P, Boniol M, La Vecchia C, LaVecchia C, Vatten L, Gavin A . Disparities in breast cancer mortality trends between 30 European countries: retrospective trend analysis of WHO mortality database. BMJ. 2010; 341:c3620. PMC: 2920378. DOI: 10.1136/bmj.c3620. View

20.

Fielder H, Warwick J, Brook D, Gower-Thomas K, Cuzick J, Monypenny I . A case-control study to estimate the impact on breast cancer death of the breast screening programme in Wales. J Med Screen. 2004; 11(4):194-8. DOI: 10.1258/0969141042467304. View